Your browser doesn't support javascript.
loading
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema.
Brown, David M; Emanuelli, Andrés; Bandello, Francesco; Barranco, Jose Juan Escobar; Figueira, João; Souied, Eric; Wolf, Sebastian; Gupta, Vishali; Ngah, Nor Fariza; Liew, Gerald; Tuli, Raman; Tadayoni, Ramin; Dhoot, Dilsher; Wang, Lixin; Bouillaud, Emmanuel; Wang, Ying; Kovacic, Lidija; Guerard, Nicolas; Garweg, Justus G.
Afiliación
  • Brown DM; Retina Consultants of Texas, Houston, TX, USA (D.M.B). Electronic address: dmbmd@retinaconsultantstexas.com.
  • Emanuelli A; Emanuelli Research and Development Center, Arecibo, Puerto Rico, USA (A.E); Department of Ophthalmology, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico (A.E).
  • Bandello F; Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy (F.B).
  • Barranco JJE; Department of Ophthalmology, Hospital Dos de Maig, Barcelona, Spain (J.J.E.B).
  • Figueira J; AIBILI - Association for Innovation and Biomedical Research on Light and Image, Azinhaga de Santa Comba, Celas, Coimbra, Portugal (J.F); Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal (J.F).
  • Souied E; Department of Ophthalmology, Hôpital Intercommunal de Creteil, Créteil, France (E.S).
  • Wolf S; Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland (S.W, J.G.G).
  • Gupta V; Advanced Eye Center, Post Graduate Institute of Medical Education and Research, Chandigarh, India (V.G).
  • Ngah NF; Hospital Shah Alam, Selangor, Malaysia (N.F.N).
  • Liew G; Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia (G.L).
  • Tuli R; The Retina Centre of Ottawa, Canada (R.T); Université de Paris, Ophthalmology Department, AP-HP, Lariboisière, Saint Louis and Fondation Adolphe de Rothschild Hospitals, Paris, France (R.T).
  • Tadayoni R; Department of Ophthalmology, University of Ottawa, Ottawa, Canada (R.T).
  • Dhoot D; California Retina Consultants/Retina Consultants of America, Santa Barbara, CA, USA (D.D).
  • Wang L; Novartis Pharma AG, Basel, Switzerland (L.W, E.B, Y.W, L.K, N.G).
  • Bouillaud E; Novartis Pharma AG, Basel, Switzerland (L.W, E.B, Y.W, L.K, N.G).
  • Wang Y; Novartis Pharma AG, Basel, Switzerland (L.W, E.B, Y.W, L.K, N.G).
  • Kovacic L; Novartis Pharma AG, Basel, Switzerland (L.W, E.B, Y.W, L.K, N.G).
  • Guerard N; Novartis Pharma AG, Basel, Switzerland (L.W, E.B, Y.W, L.K, N.G).
  • Garweg JG; Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland (S.W, J.G.G); Berner Augenklinik am Lindenhofspital and Swiss Eye Institute, Bern, Switzerland (J.G.G).
Am J Ophthalmol ; 238: 157-172, 2022 06.
Article en En | MEDLINE | ID: mdl-35038415
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Edema Macular / Diabetes Mellitus / Retinopatía Diabética / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: Am J Ophthalmol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Edema Macular / Diabetes Mellitus / Retinopatía Diabética / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: Am J Ophthalmol Año: 2022 Tipo del documento: Article